GOLM1 and posterior cortical atrophy: Golgi phosphoprotein-2, a Golgi membrane antigen encoded by GOLPH2, is reported to be overexpressed in almost 90% of PCa patients, it does not only serve as a suitable biomarker for early diagnosis but also helps in distinguishing normal cells from cancerous cells [84].